Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7-epi-hydroxystaurosporine
2. 7-hydroxy-staurosporine
3. 7-hydroxystaurosporine
4. 8,12-epoxy-1h,8h-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)triinden-1-one, 2,3,9,10,11,12-hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)-
5. Ucn 01
6. Ucn 02
7. Ucn-02
1. Ucn-02
2. Chembl574737
3. 121569-61-7
4. Ucn 02
5. Kw-2401
6. Ucn01
7. Schembl16946789
8. Dtxsid60923867
9. Hms3229l19
10. Bdbm50280450
11. Nsc800958
12. Zinc33901069
13. Nsc-800958
14. Ncgc00346827-02
15. Ucn-01, >=97% (hplc), Powder
16. 8,12-epoxy-1h,8h-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)-
17. 9,13-epoxy-1h,9h-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazon-1-one, 2,3,10,11,12,13-hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)-, (3-alpha,9-alpha,10-beta,11-beta,13-alpha)-
18. Hy-108262
19. Cs-0027882
20. (2s,3r,4r,6r,18s)-18-hydroxy-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one
21. 18-hydroxy-3-methoxy-2-methyl-4-methylamino-(2r,3s,4s,6s)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8(13),9,11,14(28),15(19),20(27),21(26),22,24-nonaen-16-one
22. 8-methoxy-9-methyl-7-(methylamino)-6,7,8,9-tetrahydro-5h,14h-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacene-14,16-diol
| Molecular Weight | 482.5 g/mol |
|---|---|
| Molecular Formula | C28H26N4O4 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 482.19540532 g/mol |
| Monoisotopic Mass | 482.19540532 g/mol |
| Topological Polar Surface Area | 89.7 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 935 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
ABOUT THIS PAGE
A 7-Hydroxystaurosporine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 7-Hydroxystaurosporine, including repackagers and relabelers. The FDA regulates 7-Hydroxystaurosporine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 7-Hydroxystaurosporine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 7-Hydroxystaurosporine supplier is an individual or a company that provides 7-Hydroxystaurosporine active pharmaceutical ingredient (API) or 7-Hydroxystaurosporine finished formulations upon request. The 7-Hydroxystaurosporine suppliers may include 7-Hydroxystaurosporine API manufacturers, exporters, distributors and traders.
click here to find a list of 7-Hydroxystaurosporine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 7-Hydroxystaurosporine DMF (Drug Master File) is a document detailing the whole manufacturing process of 7-Hydroxystaurosporine active pharmaceutical ingredient (API) in detail. Different forms of 7-Hydroxystaurosporine DMFs exist exist since differing nations have different regulations, such as 7-Hydroxystaurosporine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 7-Hydroxystaurosporine DMF submitted to regulatory agencies in the US is known as a USDMF. 7-Hydroxystaurosporine USDMF includes data on 7-Hydroxystaurosporine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 7-Hydroxystaurosporine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 7-Hydroxystaurosporine suppliers with USDMF on PharmaCompass.
7-Hydroxystaurosporine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 7-Hydroxystaurosporine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 7-Hydroxystaurosporine GMP manufacturer or 7-Hydroxystaurosporine GMP API supplier for your needs.
A 7-Hydroxystaurosporine CoA (Certificate of Analysis) is a formal document that attests to 7-Hydroxystaurosporine's compliance with 7-Hydroxystaurosporine specifications and serves as a tool for batch-level quality control.
7-Hydroxystaurosporine CoA mostly includes findings from lab analyses of a specific batch. For each 7-Hydroxystaurosporine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
7-Hydroxystaurosporine may be tested according to a variety of international standards, such as European Pharmacopoeia (7-Hydroxystaurosporine EP), 7-Hydroxystaurosporine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (7-Hydroxystaurosporine USP).
LOOKING FOR A SUPPLIER?
